Pacific RxTracts - March 2026

Authors

Pacific RxTracts

Files

Description

Articles:

• FDA Approves Zycubo as First Treatment for Menkes Disease
• A Step Toward New Lung Treatment - FDA Expands Nerandomilast Approval
• Olezarsen for Severe Hypertriglyceridemia and Pancreatitis Prevention
• Increasing Accessibility of Treatment for Hepatitis C Through Telemedicine
• Efficacy of a Shortened Romosozumab Therapy followed by Denosumab in Postmenopausal Osteoporosis
• Renal Outcomes of SGLT2 Inhibitors vs. GLP-1 Receptor Agonists in T2D
• Plozasiran, A Novel Therapy for Familial Chylomicronemia Syndrome
• Incretin Agonists and Reduced CPAP Use in Obesity-Related Obstructive Sleep Apnea
• Icotrokinra: A Novel Oral Therapy for Plaque Psoriasis
• Omega-3 Fatty Acids in Pediatric Major Depressive Disorder: Limited Benefit as Adjunctive Therapy
• Effectiveness of Intranasal Esketamine in Treatment-Resistant Depression
• Long-Term Efficacy and Safety of Lecanemab in Early Alzheimer's Disease
• AMBITION Protocol for Cryptococcus Meningitis: A Safer Alternative
• FDA Green-Lights D-VRd Quadruplet for Newly Diagnosed Multiple Myeloma
• Efficacy of New Triple Combination Therapy in Follicular Lymphoma
• Advancing First-Line Treatment in TNBC: Sacituzumab Govitecan plus Pembrolizumab
• A New Role for an Established Drug: Palbociclib in HER2-Positive Breast Cancer

Publication Date

3-5-2026

Volume

23

Issue

5

Pages

10

Publisher

University of the Pacific

City

Stockton, CA

Disciplines

Medicine and Health Sciences | Pharmacy and Pharmaceutical Sciences

Recommended Citation

Pacific RxTracts, "Pacific RxTracts - March 2026" (2026). Pacific RxTracts. 14.
https://scholarlycommons.pacific.edu/rx-tracts/14